Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

OBJECTIVES: To evaluate the discrimination, calibration, and net benefit performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) across five European randomized study of screening for prostate cancer (ERSPC), 1 United Kingdom, 1 Austrian, and 3 US biopsy cohorts. METHODS: PCPTRC...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Ankerst, D, Boeck, A, Freedland, S, Thompson, I, Cronin, A, Roobol, M, Hugosson, J, Stephen Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Moreira, D, Schröder, F, Lilja, H, Vickers, A
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: 2012